Accelerate licensing & partnership decisions
De-risk in-licensing decisions and move faster on the right programs
Identify, track, and triage the best drug programs
95% of deals do not pass due diligence processes and simply waste time, effort, and resources. Efficiently sift through hundreds of opportunities with VibeOne and focus on only those that truly align with your strategy.

Speed
Build focused opportunity lists in days vs. months

Scale
Evaluate hundreds of assets with fewer resources

Trust
Transparent, traceable scoring ensures defensive, data-backed decisions

Global
Seamlessly integrate non-English data, uncovering overlooked assets

Comprehensive top-to-bottom diligence
Accelerate search & evaluation
Save time and money while streamlining due diligence with VibeOne.
Challenges vs. advantages: How VibeOne delivers
Challenge
- Volume overload: Hundreds of early-stage opportunities
- Resource bottlenecks: Low-value assets waste time and energy
- Biased decision-making: Familiarity and recency biases result in poor decisions
- Language & regional barriers: Lack of in-house foreign language skills results in missed opportunities
VibeOne advantage
- Scale intelligently: Narrow focus with data-powered research instead of brute-force screening
- Efficiency boost: Eliminate poor fits early and assign internal experts only to high-probability assets
- Objective rigor: Apply consistent, transparent evaluation frameworks across programs and indications
- Global intelligence: Automatically translate and contextualize data from foreign biopharmas (e.g. Chinese drug programs)
Uncover new possibilities with VibeOne
Learn how VibeOne evaluates and compares drug assets, helping you identify high potential development opportunities more quickly.